Implementing sustainable construction methods
In 2016, our UK-based global R&D Centre and Corporate HQ will relocate to a purpose-built facility on the Cambridge Biomedical Campus. The 2,000-person site will house the majority of the staff currently located in three existing UK sites.
AstraZeneca took the decision early on in the project to work with our partners to deliver a sustainable design for the facility, capable of achieving Building Research Establishment Environmental Assessment Methodology (BREEAM) ‘Excellent’ ratings for sustainability performance. In order to achieve this, the facility must gain 70% of the available credits.
The R&D Centre has 73% of these credits confirmed with a further 12.7% being targeted, while the R&D Enabling Building has 74% of its credits confirmed with a further 16.7% of the score being targeted.
Many of the steps taken to reduce energy consumption on the site have been based on learning from our existing Gothenburg R&D site in Sweden, which is a best-practice example from an energy use perspective. For example, the optimisation of natural light, a combined heat and power station and a rainwater recovery system reduce energy consumption and the environmental footprint of the facility. Per scientist, the Cambridge site will be twice as energy efficient as Gothenburg.